Access cutting-edge peripartum cardiomyopathy treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.
Access peripartum cardiomyopathy specialists in Los Angeles at no cost
This study follows strict safety protocols and ethical guidelines
All study-related peripartum cardiomyopathy treatment provided free
The study will enroll 200 women newly diagnosed with peripartum cardiomyopathy within 5 months postpartum in a randomized placebo controlled trial of bromocriptine therapy to evaluate its impact on myocardial recovery and clinical outcomes. Given that bromocriptine prevents breastfeeding, an additional 50 women with peripartum cardiomyopathy excluded from the trial due to a desire to continue breastfeeding but meeting all other entry criteria will be followed in an observational cohort.
Sponsor: Dennis M. McNamara, MD, MS
Check if you qualify for this peripartum cardiomyopathy clinical trial in Los Angeles, CA
If you're searching for peripartum cardiomyopathy treatment options in Los Angeles, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced peripartum cardiomyopathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.